Fusidic acid and insulin-dependent diabetes mellitus

Autoimmunity

Volumn 24, Issue 3, 1996, Pages 187-197

  Nicoletti, Ferdinando ^a   Meroni, Pier Luigi ^a   Bendtzen, Klaus ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Rigshospitalet   (Denmark)

Author keywords

Fusidic acid; Immunosuppression; Insulin dependent diabetes mellitus; Treatment

Indexed keywords

ANTIBIOTIC AGENT; FUSIDATE SODIUM; FUSIDIC ACID;

ANIMAL MODEL; AUTOIMMUNITY; CLINICAL TRIAL; ECZEMA; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RASH; REVIEW; URTICARIA;

EID: 0030478744     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939608995364     Document Type: Review

References (45)

1. Castan̄o, L, Eisenbarth, G. S. Type-1 diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 1990; 8: 647-679.
2. Bach, J. F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 1994; 15: 516-542.
3. Bottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, G. F., Gamble, D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 1985; 313: 353-360.
4. Mordes, J. P., Desemone, J., Rossini, A. A. The BB rat. Diabetes. Metab. Rev. 1987; 3: 725-750.
5. Kolb, H., Kolb-Bachofen, V., Roep, B. O. Autoimmune versus inflammatory type 1 diabetes: A controversy? Immunol. Today. 1995; 16: 170-172.
6. Bottazzo, G. F., Foulis, A. K., Bosi, E., Todd, I., Pujol-Borrell, R. Pancreatic beta-cell damage. In search of novel pathogenetic factors. Diabetes Care 1988; 11 Suppl 1: 24-28.
7. Bcndtzcn, K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic diseases and endocrine diseases. Autoimmunity 1989; 2: 177-189.
8. Rabinovitch, A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation? Diabetes 1994; 43: 613-621.
9. Corbett, J. A., McDaniel, M. L. Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J. Exp. Med. 1995; 181: 559-568.
10. Bendtzen, K. Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., Svenson, M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545-1547.
11. Mandrup-Poulsen, T., Helqvist, S., Molvig, J., Wogensen, L. D., Nerup, J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989; 4: 191-218.
12. Nicoletti, F., Meroni, P. L., Barcellini, W., Grasso, S., Borghi, M. O., Lunetta, M., et al FK-506 prevents diabetes in diabetes-prone BB/Wor rats. Int. J. Immunopharmacol 1991; 13: 1027-1030.
13. Cavallo, M. C., Pozzilli, P., Bird, C., Wadhwa, M., Meager, A., Visalli, N., et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin. Exp. Immunol. 1991; 86: 256-259.
14. Nicoletti, F., Meroni, P. L., Landolfo, S., Gariglio, M., Guzzardi, S., Barcellini, W., et al. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ. Lancet 1990; 336: 319.
15. Campbell, I. L, Kay, T. W. H., Oxbrow, L., Harrison, L. C. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 1991; 87: 739-742.
16. Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 1991; 4: 237-248.
17. Dayer-Metroz, M. D., Duhamel, D., Rufer, N., Izui, S., Carmichaels, D., Wollheim, C. B., et al. IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats. Eur. J. Clin. Invest, 1992; 22: A50 (Abstract).
18. Nicoletti, F., Di Marco, R., Barcellini, W., Magro, G., Schorlemmer, H. U., Kurrle, R., et al. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur. J. Immunol. 1994; 24: 1843-1847.
19. Pennline, K. J., Roque-Gaffney, E., Monahan, M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 1994; 71: 169-175.
20. Yang, X-D., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D., et al. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 1994; 180: 995-1004.
21. Sarvetnick, N., Shizuru, J., Liggitt, D., Martin, L., McIntyre, B., Gregory, A., et al. Loss of pancreatic islet tolerance induced by beta-cell expression of interferongamma. Nature 1990; 346: 844-847.
22. Katz, J. D., Benoist, C., Mathis, D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 268: 1185-1188.
23. Corbett, J. A., Mikhael, A., Shimizu, J., Frederick, K., Misko, T. P., McDaniel, M. L., et al. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and - resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA 1993; 90: 8992-8995.
24. Eizirik, D. L, Sandier, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest 1994; 93: 1968-1974.
25. Wu, G. Nitric oxide synthesis and the effect of aminoguanidine and NG-monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes, 1995; 44: 360-364.
26. Ziegler, A. G., Ziegler, R., Vardi, P., Jackson, R. A., Soeldner, J. S., Eisenbarth, G. S. Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 1989; 38: 1320-1325.
27. Skyler, J. S., Marks, J. B. Immune intervention in type 1 diabetes mellitus. Diabetes Review 1993; 1: 15-42.
28. Godtfredsen, W. O., Jahnsen, S., Lorck, H., Roholt, K., Tybring, L. Fusidic acid: a new antibiotic. Nature 1962; 193: 987.
29. von Daehne, W., Godtfredsen, W. O., Rasmussen, P. R. Structure-activity relationships in fusidic acid-type antibiotics. Adv. Appl. Microbiol. 1979; 25: 95-146.
30. Bellahsene, A., Forsgren, A. Effect of fusidic acid on the immune response in mice. Infect. Immun. 1980; 29: 873-878.
31. Bendtzen, K., Diamant, M., Faber, V. Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine 1990; 2: 423-429.
32. Nicoletti, F., Di Marco, R., Morrone, S., Zaccone, P., Lembo, D., Grasso, S., et al. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma. Immunology 1994; 81: 317-321.
33. Nicoletti, F., Zaccone, P., Di Marco, R., Magro, G., Grasso, S., Morrone, S., et al. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology 1995; 85: 645-650.
34. Chen, Y-L., Le Vraux, V., Giroud, J-P., Chauvelot-Moachon, L. Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses. Eur. J. Pharmacol. 1994; 271: 319-327.
35. Tanaka, N., Kinoshita, T., Masukawa, H. Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. Biochem. Biophys. Res. Commun. 1968; 30: 278-283.
36. Reeves, D. S. The pharmacokinetics of fusidic acid. J. Antimicrob. Chemother. 1987; 20: 467-476.
37. Nicoletti, F, Meroni, P. L., Lunetta, M., Vigo, R., Palermo, T., Papalia, D., et al Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus. Lancet 1991; 337: 1292.
38. Buschard, K., Pedersen, C., Hansen, S. V., Hageman, I., Aaen, K., Bendtzen, K. Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats. Autoimmunity 1992; 14: 101-104.
39. Bendtzen, K., Diamant, M., Horn, T., Pedersen, C., Buschard, K. Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic β-cell functions in rats. J. Endocrinol. 1992; 132: 345-352.
40. Burkart, V., Bellmann, K, Hartmann, B., Heller, B., Imai, Y., Kolb, H. Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells. Biochem. Pharmacol. 1994; 48: 1379-1385.
41. Horn, T., Bendtzen, K., Hageman, I., Buschard, K. Morphological effects of sodium fusidate (fusidin) on pancreatic islet cells: An electron microscopic study. Pharmacol. Toxicol. 1994; 75: 228-230.
42. Famularo, G., De Simone, C., Tzantzoglou, S., Trinchieri, V., Moretti, S., Tonietti, G. In vivo and in vitro efficacy of fusidic acid in HIV infection. Ann. N. Y. Acad. Sci. 1993; 685: 341-343.
43. Bendtzen, K., Vesti-Nielsen, N., Petersen, J., Andersen, V., Bendixen, G. Treatment of chronic endogenous uveitis with fusidic acid. Lancet 1991; 337: 552-553.
44. Langholz, E., Brynskov, J., Bendtzen, K., Vilien, M., Binder, V. Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin. Aliment. Pharmacol. Thier. 1992; 6: 495-502.
45. Findon, G., Miller, T. E., Rowe, L. C. Pharmacokinetics of fusidic acid in laboratory animals. Lab. Anim. Sci. 1991; 41: 462-465.